Generation of phenothiazine with potent anti-tlk1 activity for prostate cancer therapy

HIGHLIGHTS

• who: Vibha Singh from the of Biochemistry and Molecular Biology, LSU Health Sciences Center, Shreveport, USA have published the Article: Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy, in the Journal: (JOURNAL) of September/25,/2020
• what: The authors have carried out some structure-activity relationship studies and molecular modeling to explain why, and for simplicity, the authors show below a comparison between THD and J54. In Table S3, related to Figure 2D, the authors show the results obtained at effective concentrations of 100 nM for J54 compared with THD, which . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.